about
MDA5-positive dermatomyositis: an uncommon entity in Europe with variable clinical presentationsThe importance of including amyopathic dermatomyositis in the idiopathic inflammatory myositis spectrumAmyopathic Dermatomyositis: A Concise Review of Clinical Manifestations and Associated Malignancies.Anti-MDA5 antibody as a potential diagnostic and prognostic biomarker in patients with dermatomyositisClinical presentation and evaluation of dermatomyositis.The lung as a possible target for the immune reaction in myositis.Interstitial lung diseases in the hospitalized patient.Epidemiologic study of clinically amyopathic dermatomyositis and anti-melanoma differentiation-associated gene 5 antibodies in central Japan.Adult and juvenile dermatomyositis: are the distinct clinical features explained by our current understanding of serological subgroups and pathogenic mechanisms?A novel dermato-pulmonary syndrome associated with MDA-5 antibodies: report of 2 cases and review of the literature.Childhood Arthritis and Rheumatology Research Alliance consensus clinical treatment plans for juvenile dermatomyositis with skin predominant disease.Clinical features, pathogenesis and treatment of juvenile and adult dermatomyositis.Utility of anti-melanoma differentiation-associated gene 5 antibody measurement in identifying patients with dermatomyositis and a high risk for developing rapidly progressive interstitial lung disease: a review of the literature and a meta-analysisMyositis specific and associated autoantibodies in the diagnosis and management of juvenile and adult idiopathic inflammatory myopathies.Neutrophil extracellular traps may contribute to interstitial lung disease associated with anti-MDA5 autoantibody positive dermatomyositis.Clinically amyopathic dermatomyositis: clinical features, response to medications and malignancy-associated risk factors in a specific tertiary-care-centre cohort.Anti-MDA5-Positive Dermatomyositis Presenting as Fever of Unknown Origin.Clinical and serological features of patients with dermatomyositis complicated by spontaneous pneumomediastinum.Fulminant systemic capillary leak syndrome due to C1 inhibitor deficiency complicating acute dermatomyositis: a case report.A Case of Polymyxin b-Immobilized Fiber Column Treatment for Rapidly Progressive Interstitial Pneumonia Associated with Clinically Amyopathic DermatomyositisClinical effects of direct hemoperfusion using a polymyxin B-immobilized fiber column in clinically amyopathic dermatomyositis-associated rapidly progressive interstitial pneumonias[Early symptoms of dermatomyositis and antisynthetase syndrome].Autoantibodies against TIF-1-γ and CADM-140 in Spanish patients with clinically amyopathic dermatomyositis (CADM): clinical significance and diagnostic utility.In vivo measurement of membrane permeability and myofiber size in human muscle using time-dependent diffusion tensor imaging and the random permeable barrier model.The Serum Ferritin Level Is Associated with the Treatment Responsivity for Rapidly Progressive Interstitial Lung Disease with Amyopathic Dermatomyositis, Irrespective of the Anti-MDA5 Antibody Level.Early diagnosis and treatment for remission of clinically amyopathic dermatomyositis complicated by rapid progress interstitial lung disease: a report of two cases.Successful treatment of plasma exchange for rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis: A case report.Interstitial lung disease in clinically amyopathic dermatomyositis (CADM) patients: a retrospective study of 41 Chinese Han patients.A Case of Clinically Amyopathic Dermatomyositis with Interstitial Pneumonia that Was Successfully Treated with Plasma Exchange.Distinct profiles of myositis-specific autoantibodies in Chinese and Japanese patients with polymyositis/dermatomyositis.Prevalence and reactivity of anti-melanoma differentiation-associated gene 5 (anti-MDA-5) autoantibody in Brazilian patients with dermatomyositisSerum interferon-α is a useful biomarker in patients with anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis
P2860
Q26777975-2FE24A14-3E49-4054-94F8-50CD58F29359Q27014908-FCE6D4A5-9BBB-4B77-8505-9C666A57223AQ30249874-3FF90EE3-E2B0-4B98-86E4-8127B87FA87CQ33688739-1424AACF-3882-46B8-A18D-B5175FEE7B56Q34644756-4AFA298F-58F7-46F8-981B-18F5AE3E12D6Q35617570-6E0B2435-F19B-40B8-B91E-F2F54BC51C80Q35788902-D0AF9BE1-AC2E-4353-B020-C4B2E2BA0168Q35907850-90B90EE4-1CBE-461D-92AB-E584AA0F75C0Q36903076-3BE319C9-58B1-416A-A2E0-8344F676A10EQ37053219-960EFD11-C488-4FAF-BDAD-0294188491D9Q37579105-65A74A2C-CA85-499D-AB16-DE3E5061738DQ37938701-215CC36B-2C39-4CA6-9F15-4E59A39F519CQ38125957-3B23F2DB-E801-4C47-85CE-361D0833E21CQ38281749-C4F6E47F-B512-4A11-9BA6-6F67E7FFD8D6Q38607528-0E68D4BE-DE4A-4EF1-ABC0-BDCC66328BF9Q38613540-CD0DA4DE-57FE-447A-83B6-BAFBA759480DQ38879035-199667A9-8049-4C00-AA44-DC3998D9EB86Q40763019-A3C7DB4E-8A60-44FA-9546-EED03A793CB6Q41930456-47525C46-3080-4232-89D2-97B11D49AF8AQ42146244-5B66EA6D-E884-40E5-B6F1-23FABAFA9F41Q42634230-875EAF20-8955-483A-ABBD-BC86E5F363EDQ44920626-D9236184-B3EB-4138-BD2D-CCACB7E9D457Q45052982-53F19A5E-061E-4AAF-BAB7-7CCF68FC404CQ47268909-DB4BDC01-5EE3-452C-B7CA-5FD7CBC80137Q47726169-9337AF31-2A3E-413E-8EC2-6DABC9FE8200Q47966613-48845648-EB13-4AAD-A885-1D70EDCEFB23Q52593825-8F76239A-CD62-4BC1-9D23-EA7C85D290B2Q53133315-286A4964-ACC7-4BA4-BAA7-90968CB04C7AQ53705735-46EA5659-730C-46F7-BB12-00525DF0CCC2Q54276160-F29F439C-F934-4BE5-9510-7BA02CBCF81EQ57753744-1584E362-228D-4301-B369-BFA30DE05376Q57755036-AA3EB38A-7CA9-4AF8-9721-6EF4CFF11B83
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Clinically amyopathic dermatomyositis.
@en
Clinically amyopathic dermatomyositis.
@nl
type
label
Clinically amyopathic dermatomyositis.
@en
Clinically amyopathic dermatomyositis.
@nl
prefLabel
Clinically amyopathic dermatomyositis.
@en
Clinically amyopathic dermatomyositis.
@nl
P1476
Clinically amyopathic dermatomyositis.
@en
P2093
Masataka Kuwana
Shinji Sato
P304
P356
10.1097/BOR.0B013E32833F1987
P577
2010-11-01T00:00:00Z